International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2024
Indexing Partners
Novel Beta Lactam Antibiotics for the Management of Pediatric Gram-negative Infections Resistant to Multi Drugs
Author(s) | Vikas N. Nighot, Akshada D. Suryawanshi, Tejas J. Mharse, Dhanashri S. Pawar |
---|---|
Country | India |
Abstract | Infections due to carbapenem- resistant Enterobacter ales (CRE) are increasingly prevalent in children and are associated with poor clinical issues, especially in critically ill cases. new beta lactam antibiotics, including ceftolozane- tazobactam, ceftazidime- avibactam, meropenem- vaborbactam, imipenem- cilastatin- relebactam, and cefiderocol, have been released in recent times to face the arising challenge of multidrug- resistant (MDR) Gram-negative bacteria. Nevertheless, several new agents warrant pediatric suggestions approved by the Food and Drug Administration FDA) and the European Medicine Agency (EMA), leading to uncertain pediatric-specific treatment strategies and uncertain dosing rules in the pediatric population. In this narrative review we have epitomized the available clinical and pharmacological data, current limitations and unborn prospects of new beta lactam antibiotics in the pediatric population. |
Keywords | Children, multidrug resistance, pediatric, gram-negative bacterial infection, Safety and efficacy, dose, adverse effects. |
Field | Chemistry > Pharmacy |
Published In | Volume 5, Issue 6, November-December 2023 |
Published On | 2023-12-23 |
Cite This | Novel Beta Lactam Antibiotics for the Management of Pediatric Gram-negative Infections Resistant to Multi Drugs - Vikas N. Nighot, Akshada D. Suryawanshi, Tejas J. Mharse, Dhanashri S. Pawar - IJFMR Volume 5, Issue 6, November-December 2023. DOI 10.36948/ijfmr.2023.v05i06.10480 |
DOI | https://doi.org/10.36948/ijfmr.2023.v05i06.10480 |
Short DOI | https://doi.org/gs98vt |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.